FDA Clears Glucose Monitors for Kids as Young as 2

Millions of American families just gained access to a health tool that could help protect their kids from a growing crisis.

The FDA recently cleared Dexcom's Stelo glucose monitor for over-the-counter use in children as young as 2 years old. These wearable devices track blood sugar levels around the clock, providing real-time data that helps families understand how food and exercise affect their child's health.

The timing matters. An estimated 1 in 3 American teens now have prediabetes or type 2 diabetes, and 1 in 5 children live with obesity. Without early intervention, these kids face serious health challenges as they grow up.

Dr. Kristen Nadeau, a pediatric endocrinologist at Children's Hospital Colorado, sees the approval as potentially life-changing for families she works with. The biggest barrier to getting her patients a glucose monitor has always been cost and insurance coverage, especially for children not yet on insulin therapy who could benefit most from early tracking.

At $99 per month for two 15-day sensors, Stelo costs far less than prescription options. That price point could finally put these devices within reach of underserved families whose children are at high risk for diabetes.

Julie Wilson, a clinical dietitian at Rady Children's Health in San Diego, believes the real-time feedback could motivate healthy changes better than traditional education. "It would be giving them a little bit more knowledge, more of an ability to see what is happening," she said. "I think it would cause some dietary change."

The devices work by placing a tiny sensor under the skin that samples blood sugar every 15 minutes. Families can track patterns and make informed decisions about meals, snacks, and activity levels.

The Bright Side

While some pediatricians worry about data overload in healthy children, the FDA's decision prioritizes access for the families who need it most. Kids with obesity, prediabetes, or type 2 diabetes who don't take insulin rarely get insurance coverage for prescription monitors, leaving them without crucial health information.

Now those families can take action before minor problems become major ones. Early awareness of blood sugar patterns can help children avoid progressing to full diabetes and the serious complications that come with it.

The approval also signals growing recognition that childhood metabolic health deserves the same monitoring tools available to adults. As chronic conditions start earlier in life, giving families affordable ways to track and respond makes preventive care possible for everyone, not just those with insurance coverage.

More glucose monitor companies are likely to follow Dexcom's lead and seek approval for their over-the-counter devices in children, potentially driving prices down even further while expanding choices for families.